A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer
Clinical trial NCT04425876 · UNKNOWN
Trial details
- NCT number
- NCT04425876
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2023-03-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.